Prof Justin Stebbing, MD, PhD

Professor Justin Stebbing is a Non-Executive Director and Chair of the Scientific Advisory Board at Onconox, providing leadership across scientific strategy, translational development, and clinical innovation. An internationally recognized oncologist and researcher, he has authored more than 800 peer-reviewed publications advancing the understanding and treatment of cancer and serves as Editor-in-Chief of Oncogene, one of the world’s leading cancer research journals. Professor Stebbing has led numerous clinical trials and advised global biotech and pharmaceutical companies on translational design and biomarker strategy. His scientific acumen and clinical insight are central to shaping Onconox’s R&D direction and guiding the advancement of the BIG Platform toward clinical validation.